For the Inventor, By the Inventor

Enter assignee name

Hanmi Holdings Co., Ltd.

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 10

Forward Citations = 124

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Gwan Sun Lee (7 out of 44 patents)

Sung Youb Jung (3 out of 62 patents)

Se Chang Kwon (3 out of 89 patents)

4. Dae Hae Song (3 out of 15 patents)

5. Gwan-Sun Lee (3 out of 23 patents)

6. Se-Chang Kwon (3 out of 6 patents)

7. Tae Hee Ha (2 out of 17 patents)

8. Young Min Kim (2 out of 73 patents)

9. Maeng Sup Kim (2 out of 14 patents)

10. Mi Young Cha (2 out of 7 patents)

11. Young-Kil Chang (2 out of 21 patents)

12. Jaeho Yoo (2 out of 2 patents)

13. Jin Sun Kim (2 out of 10 patents)

14. Se Young Kim (2 out of 4 patents)

15. Eun Young Kim (2 out of 28 patents)

12 patents: Sort by Forward Citations

1. 8349969 - Method for preparing high-purity polyethyleneglycol aldehyde derivatives (2013-01-08),

2. 8242288 - Method of preparing (6R)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method (2012-08-14),

3. 8217174 - Method of preparing montelukast and intermediates used therein (2012-07-10),

4. 8188102 - Amide derivative for inhibiting the growth of cancer cells (2012-05-29),

5. 8163889 - Physiologically active polypeptide conjugate having prolonged in vivo half-life (2012-04-24),

6. 8124094 - Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same (2012-02-28),

7. 8110665 - Pharmaceutical composition comprising an immunoglobulin FC region as a carrier (2012-02-07),

8. 8106076 - Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same (2012-01-31),

9. 8029789 - Method for the mass production of immunoglobulin constant region (2011-10-04),

10. 8003658 - Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof (2011-08-23),

11. 7968316 - Method for the mass production of immunoglobulin Fc region deleted initial methionine residues (2011-06-28),

12. 7888511 - Method of preparing esomeprazole and salts thereof (2011-02-15),

Hanmi Holdings Co., Ltd. is a leading global pharmaceutical company based in South Korea. With a mission to improve people's lives through innovative healthcare solutions, Hanmi Holdings engages in the research, development, manufacture, and sale of various pharmaceutical products. The company specializes in areas such as oncology, diabetes, cardiovascular diseases, and rare diseases. With a strong commitment to quality, Hanmi Holdings has established a global presence and strives to be a trusted partner in the global healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

12 Patents

#36 in

#899 in South Korea

#46,762 in the World

Hanmi Holdings Co., Ltd.

Forward Citations = 124

65 inventors:

Gwan Sun Lee (7 out of 44 patents)

Sung Youb Jung (3 out of 62 patents)

Se Chang Kwon (3 out of 89 patents)

4. Dae Hae Song (3 out of 15 patents)

5. Gwan-Sun Lee (3 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…